On August 28, 2026, Doximity Inc (DOCS) shares rose 4.5% to a current price of $26.73. This performa

On August 27, 2026, Doximity Inc (DOCS) shares rose 3.4% to a current price of $25.59, reflecting a

MedPeer,Inc. (OTCMKTS:MDPEF - Get Free Report) and Doximity (NYSE: DOCS - Get Free Report) are both

[url="]Doximity[/url], Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professional

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. m

DOCS' AI expansion is opening new growth avenues, but rising AI costs and tight pharma budgets could

Barclays analyst Glen Santangelo maintains Doximity (NYSE:DOCS) with a Equal-Weight and raises th

This sale was executed under a pre-established Rule 10b5-1 trading plan adopted in February.

The transaction involved the exercise of options and a subsequent disposition valued at $140,400 at

The shares traded represent about $111,154 in total value based on the execution price on August 15.

The disposition involved 15,311 shares valued at about $380,000 based on a weighted average price of

The CEO disposed of 8,505 shares for approximately $211,000 based on the transaction-date pricing. T

Small caps hit fresh highs Friday as soft retail sales and weak sentiment stalled the S&P 500, w

Doximity (DOCS), a digital platform for US medical professionals, rose 0.46% premarket after Truist

Truist Securities analyst Jailendra Singh maintains Doximity (NYSE:DOCS) with a Hold and raises t

Recent commentary in the DevSecOps sector has been positive, which could help fuel GitLab's revenue.

Apple just got slapped with an Underperform rating while Trade Desk faces a brutal price target, but

Wells Fargo analyst Stan Berenshteyn downgrades Doximity (NYSE:DOCS) from Equal-Weight to Underwe

Doximity's AI assistant is earning favorable reviews from independent researchers. Customer usage of

Doximity delivered strong fiscal Q1 2027 results, validating my prior bullish stance on valuation an

Doximity NYSE: DOCS reported fiscal 2027 first-quarter revenue of $157 million, up 7% from a year ea

U.S. stocks rose, Nasdaq Composite up 1%. Natera Inc (NTRA) shares jump 20.5% after strong Q2 result

US stocks higher, Nasdaq up 300 pts. Dow +0.3%, Nasdaq +1.2%, S&P 500 +0.58%. Materials and Doxi

Tempus AI Inc. (NASDAQ: TEM) stock jumped on Friday, August 7, 2026, following strong AI healthcare

Doximity raises fiscal 2027 revenue guidance as AI adoption and pharma demand fuel growth, even as h

Doximity beat Q1 revenue estimates, raised fiscal 2027 sales guidance and highlighted strong AI adop

Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session.

Doximity, Inc. surged over 180% pre-market after its Q1 FY27 print, despite only marginally beating

Doximity (DOCS) stock as much as doubled on Friday morning after the digital platform for health car

JP Morgan analyst Alexei Gogolev maintains Doximity (NYSE:DOCS) with a Neutral and raises the pri

Piper Sandler analyst Jessica Tassan reiterates Doximity (NYSE:DOCS) with a Overweight and raises

U.S. stock futures were higher on Friday, as the Dow Jones, S&P 500 and Nasdaq 100 indices rose,

Gainers Doximity (NYSE:DOCS) stock rose 85.1% to $38.25 during Friday's pre-market session. The

Atlassian Corp (NASDAQ: TEAM) reported strong Q4 results, beating revenue and earnings estimates. St

Doximity stock is soaring after Q4 results and revised guidance. Here's what investors need to k

Gainers Doximity (NYSE:DOCS) stock increased by 65.6% to $34.22 during Thursday's after-market

Doximity (NYSE:DOCS) raises FY2027 sales outlook from $664.000 million-$676.000 million to $671.000

Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today annou

BofA downgrades Doximity (DOCS) to Underperform, slashing the price target to $20 amid soft pharma a

Top Wall Street analysts changed outlook on top stocks. See all changes including upgrades, downgrad

B of A Securities analyst Allen Lutz downgrades Doximity (NYSE:DOCS) from Buy to Underperform and

Benzinga examined the prospects for many investors' favorite stocks over the last week — here&#3

Goldman Sachs analyst David Roman maintains Doximity (NYSE:DOCS) with a Neutral and lowers the pr

Dow Jones falls 400 points, while Gemini Space Station Inc (NASDAQ: GEMI) sees 25.7% jump after stro

Barclays analyst Glen Santangelo downgrades Doximity (NYSE:DOCS) from Overweight to Equal-Weight

Jefferies analyst Brian Tanquilut downgrades Doximity (NYSE:DOCS) from Buy to Hold and lowers the

Canaccord Genuity analyst Richard Close maintains Doximity (NYSE:DOCS) with a Buy and lowers the

JP Morgan analyst Alexei Gogolev maintains Doximity (NYSE:DOCS) with a Neutral and lowers the pri

Goldman Sachs analyst David Roman maintains Doximity (NYSE:DOCS) with a Neutral and lowers the pr

U.S. stocks pushed to fresh records Thursday as Cisco's earnings beat and Nvidia's China chi